|
🐜
|
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
24 auth.
H. D. de Koning,
C. van der Aalst,
P. D. de Jong,
E. Scholten,
K. Nackaerts,
M. Heuvelmans,
J. Lammers,
C. Weenink,
U. Yousaf-Khan,
N. Horeweg,
...
S. van 't Westeinde,
M. Prokop,
W. Mali,
F. M. Mohamed Hoesein,
P. V. van Ooijen,
J. Aerts,
M. D. den Bakker,
E. Thunnissen,
J. Verschakelen,
R. Vliegenthart,
J. Walter,
K. ten Haaf,
H. Groen,
M. Oudkerk
|
10 |
2020 |
10
🐜
|
|
🐜
|
European position statement on lung cancer screening.
22 auth.
M. Oudkerk,
A. Devaraj,
R. Vliegenthart,
T. Henzler,
H. Prosch,
C. Heussel,
G. Bastarrika,
N. Sverzellati,
M. Mascalchi,
S. Delorme,
...
D. Baldwin,
M. Callister,
N. Becker,
M. Heuvelmans,
W. Rzyman,
M. Infante,
U. Pastorino,
J. Pedersen,
E. Paci,
S. Duffy,
H. D. de Koning,
J. Field
|
8 |
2017 |
8
🐜
|
|
🐜
|
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
17 auth.
N. Horeweg,
J. van Rosmalen,
M. Heuvelmans,
C. van der Aalst,
R. Vliegenthart,
E. Scholten,
K. ten Haaf,
K. Nackaerts,
J. Lammers,
C. Weenink,
...
H. Groen,
P. V. van Ooijen,
P. D. de Jong,
G. D. de Bock,
W. Mali,
H. D. de Koning,
M. Oudkerk
|
8 |
2014 |
8
🐜
|
|
🐬
|
Lung cancer LDCT screening and mortality reduction — evidence, pitfalls and future perspectives
M. Oudkerk,
Shiyuan Liu,
M. Heuvelmans,
J. Walter,
J. Field
|
8 |
2020 |
8
🐬
|
|
🐜
|
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
15 auth.
N. Horeweg,
E. Scholten,
P. D. de Jong,
C. van der Aalst,
C. Weenink,
Jan-Willem J. Lammers,
K. Nackaerts,
R. Vliegenthart,
K. ten Haaf,
U. Yousaf-Khan,
...
M. Heuvelmans,
E. Thunnissen,
M. Oudkerk,
W. Mali,
H. D. de Koning
|
8 |
2014 |
8
🐜
|
|
🐜
|
Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval
14 auth.
U. Yousaf-Khan,
C. van der Aalst,
P. D. de Jong,
M. Heuvelmans,
E. Scholten,
J. Lammers,
P. V. van Ooijen,
K. Nackaerts,
C. Weenink,
H. Groen,
...
R. Vliegenthart,
K. ten Haaf,
M. Oudkerk,
H. D. de Koning
|
7 |
2016 |
7
🐜
|
|
🐜
|
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
14 auth.
J. Walter,
M. Heuvelmans,
P. D. de Jong,
R. Vliegenthart,
P. V. van Ooijen,
Robin B. Peters,
K. ten Haaf,
U. Yousaf-Khan,
C. van der Aalst,
G. D. de Bock,
...
W. Mali,
H. Groen,
H. D. de Koning,
M. Oudkerk
|
7 |
2016 |
7
🐜
|
|
🦁
|
Lung cancer prediction by Deep Learning to identify benign lung nodules.
20 auth.
M. Heuvelmans,
P. V. van Ooijen,
S. Ather,
C. F. Silva,
D. Han,
C. Heussel,
W. Hickes,
H. Kauczor,
P. Novotny,
H. Peschl,
...
M. Rook,
R. Rubtsov,
Oyunbileg von Stackelberg,
M. Tsakok,
C. Arteta,
J. Declerck,
T. Kadir,
L. Pickup,
F. Gleeson,
M. Oudkerk
|
7 |
2021 |
7
🦁
|
|
🦁
|
Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals
10 auth.
M. Heuvelmans,
M. Oudkerk,
G. H. Bock,
H. J. Koning,
Xueqian Xie,
P. V. Ooijen,
...
M. Greuter,
P. A. Jong,
H. Groen,
R. Vliegenthart
|
6 |
2013 |
6
🦁
|
|
🦁
|
Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study.
12 auth.
M. Heuvelmans,
J. Walter,
Robin B. Peters,
G. H. Bock,
U. Yousaf-Khan,
C. M. Aalst,
...
H. Groen,
K. Nackaerts,
P. V. Ooijen,
H. J. Koning,
M. Oudkerk,
R. Vliegenthart
|
6 |
2017 |
6
🦁
|
|
🦁
|
Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening
7 auth.
M. Heuvelmans,
J. Walter,
R. Vliegenthart,
P. V. van Ooijen,
G. D. de Bock,
H. D. de Koning,
...
M. Oudkerk
|
6 |
2017 |
6
🦁
|
|
🐬
|
Volume versus diameter assessment of small pulmonary nodules in CT lung cancer screening.
D. Han,
M. Heuvelmans,
M. Oudkerk
|
5 |
2017 |
5
🐬
|
